Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 40

1.

Reporting standards for guideline-based performance measures.

Nothacker M, Stokes T, Shaw B, Lindsay P, Sipilä R, Follmann M, Kopp I; Guidelines International Network (G-I-N) Performance Measures Working Group.

Implement Sci. 2016 Jan 15;11:6. doi: 10.1186/s13012-015-0369-z.

2.

[S3 guidelines on diagnostics and treatment of cervical cancer: Demands on pathology].

Horn LC, Beckmann MW, Follmann M, Koch MC, Mallmann P, Marnitz S, Schmidt D.

Pathologe. 2015 Nov;36(6):585-93. German.

PMID:
26483249
3.

[Patient guidelines in oncology: objectives, procedures and first experiences with this format].

Schaefer C, Zowalla R, Wiesner M, Siegert S, Bothe L, Follmann M.

Z Evid Fortbild Qual Gesundhwes. 2015;109(6):445-51. doi: 10.1016/j.zefq.2015.09.013. Epub 2015 Sep 28. German.

PMID:
26474649
4.

[The German Guideline Program in Oncology (GGPO): A central core of an evidence-based, patient-centered interdisciplinary oncology?].

Langer T, Follmann M.

Z Evid Fortbild Qual Gesundhwes. 2015;109(6):437-44. doi: 10.1016/j.zefq.2015.09.007. Epub 2015 Sep 26. German.

PMID:
26474648
5.

EbM und Qualitätssicherung in der Onkologie.

Follmann M.

Z Evid Fortbild Qual Gesundhwes. 2015;109(6):415-6. doi: 10.1016/j.zefq.2015.09.001. Epub 2015 Sep 26. German. No abstract available.

PMID:
26474645
6.

Novel Small Molecule Inhibitors of Activated Thrombin Activatable Fibrinolysis Inhibitor (TAFIa) from Natural Product Anabaenopeptin.

Halland N, Brönstrup M, Czech J, Czechtizky W, Evers A, Follmann M, Kohlmann M, Schiell M, Kurz M, Schreuder HA, Kallus C.

J Med Chem. 2015 Jun 11;58(11):4839-44. doi: 10.1021/jm501840b. Epub 2015 May 20.

PMID:
25990761
7.

Discovery and pharmacological characterization of a novel potent inhibitor of diacylglycerol-sensitive TRPC cation channels.

Maier T, Follmann M, Hessler G, Kleemann HW, Hachtel S, Fuchs B, Weissmann N, Linz W, Schmidt T, Löhn M, Schroeter K, Wang L, Rütten H, Strübing C.

Br J Pharmacol. 2015 Jul;172(14):3650-60. doi: 10.1111/bph.13151. Epub 2015 May 19.

PMID:
25847402
8.

When Choosing Wisely meets clinical practice guidelines.

Strech D, Follmann M, Klemperer D, Lelgemann M, Ollenschläger G, Raspe H, Nothacker M.

Z Evid Fortbild Qual Gesundhwes. 2014;108(10):601-3. doi: 10.1016/j.zefq.2014.10.014. Epub 2014 Nov 7.

PMID:
25499114
9.
10.

Transparency is key.

Follmann M.

Dtsch Arztebl Int. 2014 Jan 17;111(3):37. doi: 10.3238/arztebl.2014.0037a. No abstract available.

11.

[S3-guideline exocrine pancreatic cancer].

Seufferlein T, Porzner M, Becker T, Budach V, Ceyhan G, Esposito I, Fietkau R, Follmann M, Friess H, Galle P, Geissler M, Glanemann M, Gress T, Heinemann V, Hohenberger W, Hopt U, Izbicki J, Klar E, Kleeff J, Kopp I, Kullmann F, Langer T, Langrehr J, Lerch M, Löhr M, Lüttges J, Lutz M, Mayerle J, Michl P, Möller P, Molls M, Münter M, Nothacker M, Oettle H, Post S, Reinacher-Schick A, Röcken C, Roeb E, Saeger H, Schmid R, Schmiegel W, Schoenberg M, Siveke J, Stuschke M, Tannapfel A, Uhl W, Unverzagt S, van Oorschot B, Vashist Y, Werner J, Yekebas E; Guidelines Programme Oncology AWMF; German Cancer Society eV; German Cancer Aid.

Z Gastroenterol. 2013 Dec;51(12):1395-440. doi: 10.1055/s-0033-1356220. Epub 2013 Dec 11. German. No abstract available.

12.

Quality assurance for care of melanoma patients based on guideline-derived quality indicators and certification.

Follmann M, Schadendorf D, Kochs C, Buchberger B, Winter A, Wesselmann S.

J Dtsch Dermatol Ges. 2014 Feb;12(2):139-47. doi: 10.1111/ddg.12238. Epub 2013 Nov 14.

PMID:
24238575
13.

5-Chlorothiophene-2-carboxylic acid [(S)-2-[2-methyl-3-(2-oxopyrrolidin-1-yl)benzenesulfonylamino]-3-(4-methylpiperazin-1-yl)-3-oxopropyl]amide (SAR107375), a selective and potent orally active dual thrombin and factor Xa inhibitor.

Meneyrol J, Follmann M, Lassalle G, Wehner V, Barre G, Rousseaux T, Altenburger JM, Petit F, Bocskei Z, Schreuder H, Alet N, Herault JP, Millet L, Dol F, Florian P, Schaeffer P, Sadoun F, Klieber S, Briot C, Bono F, Herbert JM.

J Med Chem. 2013 Dec 12;56(23):9441-56. doi: 10.1021/jm4005835. Epub 2013 Dec 3.

PMID:
24175584
14.

Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma".

Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kölbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D; German Dermatological Society; DermatologicCooperative Oncology Group.

J Dtsch Dermatol Ges. 2013 Aug;11 Suppl 6:1-116, 1-126. doi: 10.1111/ddg.12113_suppl. English, German.

PMID:
24028775
15.

The chemistry and biology of soluble guanylate cyclase stimulators and activators.

Follmann M, Griebenow N, Hahn MG, Hartung I, Mais FJ, Mittendorf J, Schäfer M, Schirok H, Stasch JP, Stoll F, Straub A.

Angew Chem Int Ed Engl. 2013 Sep 2;52(36):9442-62. doi: 10.1002/anie.201302588. Epub 2013 Aug 20. Review.

PMID:
23963798
16.
17.

S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version.

Pflugfelder A, Kochs C, Blum A, Capellaro M, Czeschik C, Dettenborn T, Dill D, Dippel E, Eigentler T, Feyer P, Follmann M, Frerich B, Ganten MK, Gärtner J, Gutzmer R, Hassel J, Hauschild A, Hohenberger P, Hübner J, Kaatz M, Kleeberg UR, Kölbl O, Kortmann RD, Krause-Bergmann A, Kurschat P, Leiter U, Link H, Loquai C, Löser C, Mackensen A, Meier F, Mohr P, Möhrle M, Nashan D, Reske S, Rose C, Sander C, Satzger I, Schiller M, Schlemmer HP, Strittmatter G, Sunderkötter C, Swoboda L, Trefzer U, Voltz R, Vordermark D, Weichenthal M, Werner A, Wesselmann S, Weyergraf AJ, Wick W, Garbe C, Schadendorf D; German Society of Dermatology.

J Dtsch Dermatol Ges. 2013 Jun;11(6):563-602. doi: 10.1111/ddg.12044. No abstract available.

PMID:
23721604
18.

Critical appraisal of clinical practice guidelines for adaptation in the evidence-based guideline "prevention of skin cancer".

Petrarca S, Follmann M, Breitbart EW, Nolte S.

JAMA Dermatol. 2013 Apr;149(4):466-71. doi: 10.1001/jamadermatol.2013.3306. Review.

PMID:
23715595
19.

[Health surveillance for workers exposed to beryllium and diagnostic procedures in beryllium-associated diseases].

Euler U, Dahmann D, Follmann M, Gaede KI, Gäßler A, Groneberg D, Heger M, Krutz K, Latza U, Lelgemann M, Letzel S, Merget R, Müller-Quernheim J, Nauert T, Seidler A; Deutsche Gesellschaft für Arbeitsmedizin und Umweltmedizin e. V.

Dtsch Med Wochenschr. 2013 Mar;138(10):488-92. doi: 10.1055/s-0032-1332900. Epub 2013 Feb 26. German. No abstract available.

PMID:
23444026
20.

Identification of acidic heterocycle-substituted 1H-pyrazolo[3,4-b]pyridines as soluble guanylate cyclase stimulators.

Griebenow N, Schirok H, Mittendorf J, Straub A, Follmann M, Stasch JP, Knorr A, Schlemmer KH, Redlich G.

Bioorg Med Chem Lett. 2013 Mar 1;23(5):1197-200. doi: 10.1016/j.bmcl.2013.01.028. Epub 2013 Jan 16.

PMID:
23385209
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk